Progressive Pathological Changes in Neurochemical Profile of the Hippocampus and Early Changes in the Olfactory Bulbs of Tau Transgenic Mice (rTg4510)
暂无分享,去创建一个
[1] John S. Kauer,et al. Pathological changes in olfactory neurons in patients with Alzheimer's disease , 1989, Nature.
[2] N. Yoshimura,et al. Down's Syndrome in Middle Age , 1990 .
[3] N. Yoshimura,et al. Down's syndrome in middle age. Topographical distribution and immunoreactivity of brain lesions in an autopsied patient. , 1990, Acta pathologica japonica.
[4] S. Provencher. Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.
[5] R Gruetter,et al. Automatic, localized in Vivo adjustment of all first‐and second‐order shim coils , 1993, Magnetic resonance in medicine.
[6] B D Ross,et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. , 1995, Radiology.
[7] C. Murphy,et al. Olfactory dysfunction in down's syndrome , 1996, Neurobiology of Aging.
[8] P. Lantos,et al. beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease. , 1999, Neuropathology and applied neurobiology.
[9] E G Tangalos,et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease , 2000, Neurology.
[10] Patrick R. Hof,et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.
[11] P Sachdev,et al. Magnetic resonance spectroscopy in AD , 2001, Neurology.
[12] John Q Trojanowski,et al. The role of tau in Alzheimer's disease. , 2002, The Medical clinics of North America.
[13] R. Kraftsik,et al. Early Olfactory Involvement in Alzheimer’s Disease , 2003, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[14] Ji-Kyung Choi,et al. Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile , 2004, Brain Research.
[15] Alexandra Flemming,et al. Infectious disease: Unravelling SARS lethality , 2005, Nature Reviews Drug Discovery.
[16] K. Ashe,et al. Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L) , 2005, The Journal of Neuroscience.
[17] Clifford R Jack,et al. Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[18] Rolf Gruetter,et al. Localized short‐echo‐time proton MR spectroscopy with full signal‐intensity acquisition , 2006, Magnetic resonance in medicine.
[19] J. Götz,et al. Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease? , 2006, Journal of neurochemistry.
[20] B. Hyman,et al. Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. , 2006, The American journal of pathology.
[21] P. Aisen,et al. A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease , 2008, Journal of Pharmacology and Experimental Therapeutics.
[22] Peter Schönknecht,et al. Reduced olfactory bulb and tract volume in early Alzheimer's disease—A MRI study , 2009, Neurobiology of Aging.
[23] M. Essig,et al. MRI-derived atrophy of the olfactory bulb and tract in mild cognitive impairment and Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.
[24] F. Zang,et al. Role of Myo-Inositol by Magnetic Resonance Spectroscopy in Early Diagnosis of Alzheimer’s Disease in APP/PS1 Transgenic Mice , 2010, Dementia and Geriatric Cognitive Disorders.
[25] J. Richardson,et al. The pathology of APP transgenic mice: a model of Alzheimer's disease or simply overexpression of APP? , 2009, Histology and histopathology.
[26] B. Hyman,et al. Caspase activation precedes and leads to tangles , 2010, Nature.
[27] Donald A. Wilson,et al. Olfactory Dysfunction Correlates with Amyloid-β Burden in an Alzheimer's Disease Mouse Model , 2010, The Journal of Neuroscience.
[28] Fei Liu,et al. Tau in Alzheimer disease and related tauopathies. , 2010, Current Alzheimer research.
[29] John Q Trojanowski,et al. Olfactory epithelium amyloid‐β and paired helical filament‐tau pathology in Alzheimer disease , 2010, Annals of neurology.
[30] Diane Stephenson,et al. Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510) , 2011, NeuroImage.
[31] Carol D. Hicks,et al. Author ' s personal copy Volumetric MRI and MRS provide sensitive measures of Alzheimer ' s disease neuropathology in inducible Tau transgenic mice ( rTg 4510 ) , 2011 .
[32] Jieun Kim,et al. Quantitative in vivo measurement of early axonal transport deficits in a triple transgenic mouse model of Alzheimer's disease using manganese-enhanced MRI , 2011, NeuroImage.
[33] S. Andrews,et al. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a “P301L” tau knockin mouse , 2012, Neurobiology of Aging.
[34] Bradley T. Hyman,et al. The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease , 2014, Neuron.
[35] R. Pautler,et al. In vivo axonal transport deficits in a mouse model of fronto-temporal dementia , 2014, NeuroImage: Clinical.
[36] Naruhiko Sahara,et al. Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study , 2014, Neurobiology of Aging.
[37] E. Mandelkow,et al. Lost after translation: missorting of Tau protein and consequences for Alzheimer disease , 2014, Trends in Neurosciences.
[38] Sébastien Ourselin,et al. In vivo imaging of tau pathology using multi-parametric quantitative MRI , 2015, NeuroImage.
[39] Holly E. Holmes,et al. Increased Cerebral Vascular Reactivity in the Tau Expressing rTg4510 Mouse: Evidence against the Role of Tau Pathology to Impair Vascular Health in Alzheimer's Disease , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[40] M. Feany,et al. Connecting the dots between tau dysfunction and neurodegeneration. , 2015, Trends in cell biology.
[41] T. Arendt,et al. Tau and tauopathies , 2016, Brain Research Bulletin.
[42] Emily C. Collins,et al. Application of neurite orientation dispersion and density imaging (NODDI) to a tau pathology model of Alzheimer's disease , 2016, NeuroImage.
[43] Beatriz Paniagua,et al. Adult rat cortical thickness changes across age and following adolescent intermittent ethanol treatment , 2016, Addiction biology.
[44] Jessica M. Sage,et al. Platelet phosphorylated TDP-43: an exploratory study for a peripheral surrogate biomarker development for Alzheimer's disease , 2017, bioRxiv.
[45] Sébastien Ourselin,et al. Comparison of In Vivo and Ex Vivo MRI for the Detection of Structural Abnormalities in a Mouse Model of Tauopathy , 2017, Front. Neuroinform..